Anthem Blue Cross and Blue Shield New Hampshire policy

LAB.00015 Detection of Circulating Tumor Cells

LAB.00015 Detection of Circulating Tumor Cells is a public Anthem Blue Cross and Blue Shield New Hampshire policy (policy LAB.00015). It lists 8 CPT or HCPCS codes, 5 of them on the Anthem Blue Cross and Blue Shield New Hampshire prior authorization list. Not a coverage decision; the payer's own document governs.

View the original policy ↗

Check eligibility for free

No account required. Sign a BAA to see plan details, coordination of benefits and more

Payer
Anthem Blue Cross and Blue Shield New Hampshire
Policy number
LAB.00015
Line of business
Commercial
Source
www.anthem.com

Codes in this policy

The CPT and HCPCS codes the policy names. A policy can name a code it excludes. Prior authorization status is from the Anthem Blue Cross and Blue Shield New Hampshire prior authorization list.

CodePrior authorizationDescription on the prior authorization listOther Anthem Blue Cross and Blue Shield New Hampshire policies
0091UNot listedPolicies naming 0091U
0337UOn the listOncology (plasma cell disorders and myeloma), circulating plasma cell immunologic selection, identification, morphological characterization, and enumeration of plasma cells based on differential CD138, CD38, CD19, and CD45 protein biomarker expression, peripheral bloodPolicies naming 0337U
0338UOn the listOncology (solid tumor), circulating tumor cell selection, identification, morphological characterization, detection and enumeration based on differential EpCAM, cytokeratins 8, 18, and 19, and CD45 protein biomarkers, and quantification of HER2 protein biomarker- expressing cells, peripheral bloodPolicies naming 0338U
0490UOn the listOncology (cutaneous or uveal melanoma), circulating tumor cell selection, morphological characterization and enumeration based on differential CD146, high molecular-weight melPolicies naming 0490U
0491UOn the listOncology (solid tumor), circulating tumor cell selection, morphological characterization and enumeration based on differential epithelial cell adhesion molecule (EpCAM), cytokPolicies naming 0491U
0492UOn the listOncology (solid tumor), circulating tumor cell selection, morphological characterization and enumeration based on differential epithelial cell adhesion molecule (EpCAM), cytokPolicies naming 0492U
86152Not listedPolicies naming 86152
86153Not listedPolicies naming 86153

All Anthem Blue Cross and Blue Shield New Hampshire policies · Anthem Blue Cross and Blue Shield New Hampshire prior authorization CPT list

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.